Benjamin Edwards’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$675K Buy
1,788
+145
+9% +$50.6K 0.01% 951
2026
Q2
$482K Buy
1,643
+261
+19% +$74K ﹤0.01% 1075
2026
Q1
$385K Buy
1,382
+379
+38% +$109K ﹤0.01% 1080
2025
Q4
$304K Buy
1,003
+245
+32% +$76.4K ﹤0.01% 1106
2025
Q3
$212K Buy
+758
New +$206K ﹤0.01% 1231
2022
Q1
– Sell
-18
Closed -$14K – 697
2021
Q4
$14K Buy
18
+14
+350% +$10.5K ﹤0.01% 550
2021
Q3
$3K Buy
+4
New +$3K ﹤0.01% 496

Other funds holding BIO

Benjamin Edwards's BIO Position: Q3 2026 in Review

Benjamin Edwards increased its Bio-Rad Laboratories Class A (BIO) stake by 8.8% in Q3 2026, buying an estimated $50.6K and bringing the position to 1,788 shares worth $675K. The position accounts for 0.01% of the portfolio, ranked #951.

Benjamin Edwards first reported a position in BIO in Q3 2021 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Benjamin Edwards held 1,788 shares of Bio-Rad Laboratories Class A worth $675K as of Q3 2026.
  • Benjamin Edwards bought 145 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $50.6K.
  • Bio-Rad Laboratories Class A made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #951 holding.
  • Benjamin Edwards first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.